SCHEMBL13861978

SCHEMBL13861978

Cc1ccc(C(F)(F)F)c(CN2CCC(N(C)C)CC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 5/20 0.44
ATM Q13315 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GAA P10253 2/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RORC P51449 1/20 0.41
POLB P06746 1/20 0.39
NR1H2 P55055 1/20 0.39
DDR1 Q08345 1/20 0.39
ACHE P22303 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14426354 0.83 KDM4E (0.51) KDM4EALDH1A1ATMNPSR1TDP1
SCHEMBL15381987 0.82 DDR1 (0.49) NR1H2DDR1
SCHEMBL10104436 0.82 RORC (0.46) NOS3NOS1NOS2KDM4EALDH1A1
SCHEMBL14426353 0.81 KDM4E (0.50) KDM4EALDH1A1ATMNPSR1TDP1
SCHEMBL13861969 0.81 MEN1 (0.50) KDM4EALDH1A1KMT2AMEN1RORC
SCHEMBL14924485 0.81 CXCR3 (0.51) KDM4EALDH1A1TDP1KMT2AMEN1
SCHEMBL14515373 0.79 HSD17B10 (0.50) KDM4EALDH1A1ATMNPSR1TDP1
SCHEMBL274217 0.78 NR1H2 (0.48) NOS3NOS1NOS2KDM4EALDH1A1
SCHEMBL24192812 0.77 NR1H2 (0.47) NOS3NOS1NOS2KDM4EALDH1A1
SCHEMBL15688063 0.77 NR1H2 (0.67) NOS3NOS1NOS2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7531553-B2 Heterocyclic compounds and methods of use AMGEN INC. (US) 2009-05-12 US disclosed
US-7531553-B2 Heterocyclic compounds and methods of use AMGEN INC. (US) 2009-05-12 US disclosed
EP-1664023-B1 SUSTITUTED ISOQUINOLINE DERIVATIVES AND METHODS OF USE AMGEN INC (US) 2008-08-13 EP disclosed
US-7390820-B2 Substituted quinolinone derivatives and methods of use AMGEN INC. (US) 2008-06-24 US disclosed
US-7390820-B2 Substituted quinolinone derivatives and methods of use AMGEN INC. (US) 2008-06-24 US disclosed